Day: February 5, 2021

SimCorp will publish its Annual Report 2020 to NASDAQ Copenhagen on Wednesday, February 10, 2021 at around 8:00 am (CET).SimCorp’s Executive Management Board will present the report at a conference call the same day at 11:00 am (CET). Please use any of the following phone numbers to dial in to the conference call:At the end of the presentation there will be a Q&A session.The powerpoint presentation will be available prior to the conference call via SimCorp’s website http://www.simcorp.com/en/about/investor/presentations-and-events/quarterly-and-annual-investor-meetings.SimCorp A/S

MANCHESTER, N.H., Feb. 05, 2021 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro”), a global leader in sensing and power semiconductor technology, announced today the pricing of a public offering of 17,500,000 shares of common stock to be sold by certain selling stockholders of Allegro at a public offering price of $30.30 per share. In addition, certain of the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 2,625,000 shares of common stock. The offering is expected to close on or about February 9, 2021, subject to the satisfaction of customary closing conditions. The selling stockholders will receive all of the net proceeds from the offering and Allegro will not receive any proceeds.Barclays, Credit Suisse, and Wells Fargo Securities are serving as joint lead book-running...

MONTREAL, Feb. 05, 2021 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX:SJ).THE PRESS RELEASE WILL BE PUBLISHED BEFORE MARKET OPENS THE DAY OF THE CONFERENCE CALL THROUGH GLOBENEWSWIRE.Please dial in 15 minutes before the conference begins.If you are unable to call in at this time, you may access a recording of the meeting by calling 1-800-585-8367 and entering the passcode 8518287 on your phone. This recording will be available on Wednesday, March 10, 2021 as of 1:00 p.m. until 11:59 p.m. on Wednesday, March 17, 2021.MEDIA WISHING TO QUOTE AN ANALYST SHOULD CONTACT THE ANALYST PERSONALLY FOR PERMISSION.For further information, please contact Pierre Boucher of MaisonBrison at 514-731-0000.

MONTRÉAL, 05 févr. 2021 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX:SJ).LE COMMUNIQUÉ SERA DIFFUSÉ PAR GLOBENEWSWIRE LE JOUR MÊME DE LA TÉLÉCONFÉRENCE AVANT L’OUVERTURE DES MARCHÉS.Veuillez téléphoner 15 minutes avant l’heure prévue pour la conférence.Si vous êtes dans l’impossibilité d’y participer, vous pourrez avoir accès à un enregistrement en téléphonant au 1-800-585-8367 et en entrant le code 8518287 sur votre clavier téléphonique. Cet enregistrement sera disponible du mercredi 10 mars 2021, à compter de 13 h 00, jusqu’à 23 h 59, le mercredi 17 mars 2021.LES MÉDIAS QUI SOUHAITERAIENT CITER UN ANALYSTE SONT PRIÉS DE CONTACTER CELUI-CI PERSONNELLEMENT POUR OBTENIR SON APPROBATION.Pour de plus amples renseignements, veuillez contacter Pierre Boucher de MaisonBrison au (514) 731-0000.

SANTA CLARA, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) — Applied Materials, Inc. will hold a webcast to discuss its first quarter of fiscal 2021 financial results on Thursday, Feb. 18, 2021 at 4:30 p.m. ET / 1:30 p.m. PT.The live webcast will be accessible via the Applied Materials website at: http://www.appliedmaterials.com/company/investor-relations. A replay will be available on the same day beginning at 8:00 p.m. ET / 5:00 p.m. PT.About Applied MaterialsApplied Materials, Inc. (Nasdaq: AMAT) is the leader in materials engineering solutions used to produce virtually every new chip and advanced display in the world. Our expertise in modifying materials at atomic levels and on an industrial scale enables customers to transform possibilities into reality. At Applied Materials, our innovations make possible the technology shaping the...

CINCINNATI, Feb. 05, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the first quarter ended December 31, 2020.First Quarter 2021 Highlights (Comparison to First Quarter Fiscal 2020):Consolidated net revenues of $92.9 million, up 96% year-over-yearLife Science segment delivered net revenues of $62.6 million, up 396% year-over-yearDiagnostics segment net revenues decreased 13% year-over-year to $30.3 million, up 2% from the fourth quarter of fiscal 2020Received a National Institutes of Health Rapid Acceleration of Diagnostics (“RADx”) grant for the development of Revogene® SARS-CoV-2 assay and submitted application to FDA for Emergency Use AuthorizationLaunched paradigm-shifting Air-Dryable Master Mix to replace lyophilization in manufacturing of molecular assaysLaunched complete...

New York, New York, Feb. 05, 2021 (GLOBE NEWSWIRE) — Alberton Acquisition Corp. (“Alberton”) (NASDAQ: ALAC) announced today that it issued 1,414,480 dividend warrants, with each warrant entitling the holder to purchase one-half ordinary share, to the public shareholders who were holders of record on April 21, 2020 and did not exercise their right to have their shares redeemed in connection with the April 2020 extension of the date on which Alberton must complete a business combination.On April 20, 2020, Alberton announced that it had agreed that if the April 2020 extension was approved, it would issue, with respect to each public share that is not redeemed in connection with April 2020 extension, one dividend warrant to purchase one-half of one ordinary share. The dividend warrants are identical to the warrants included in the units...

VANCOUVER, British Columbia, Feb. 05, 2021 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical-stage pharmaceutical company, is pleased to announce that that Moleculin Biotech Inc. (NASDAQ:MBRX) (“Moleculin”), the company that sublicenses the compound Annamycin to WPD for 29 countries mainly in Europe, announced that a preclinical study in animals demonstrated a potentially significant therapeutic benefit of Annamycin against metastatic osteosarcoma. The Moleculin press release of February 2, 2020 states, “This appears to be the result of the high cytotoxic potential of Annamycin previously demonstrated in vitro against sarcoma cells in combination with its high uptake by the lungs where the tumors in this study are localized. Computerized tomography (CT) scans demonstrated that...

DALLAS, Feb. 05, 2021 (GLOBE NEWSWIRE) — CSW Industrials, Inc. (Nasdaq: CSWI or the “Company”) today reported results for the fiscal third quarter 2021 and year-to-date periods ended December 31, 2020.Fiscal Third Quarter and Year-to-Date 2021 HighlightsQuarterly revenue of $89.9 million, a 7.4% increase (2.1% organic) compared to $83.7 million in the prior year periodQuarterly earnings per diluted common share (EPS) of $0.16, or $0.59 as adjusted to exclude transaction expenses, compared to $0.48 in the prior year periodHeating, ventilation, air conditioning, and refrigeration (HVAC/R) and architecturally specified building products (ASBP) end markets report 20.8% (15.7% organic) and 3.3% (all organic) year-to-date sales growth, respectively, over the prior year periodYear-to-date 2021 EPS of $2.06, or $2.49 adjusted...

Not for distribution to U.S. newswire services or for dissemination in the United StatesTORONTO, Feb. 05, 2021 (GLOBE NEWSWIRE) — Giyani Metals Corp. (TSXV:EMM, GR:A2DUU8) (“Giyani” or the “Company“) is pleased to provide an operations and corporate update for its K.Hill Manganese Project (“K.Hill”) in Southern Botswana.Robin Birchall, CEO of the Company commented:“We are very pleased to bring the market up to date on a number of operational and corporate activities. Concurrent to the ongoing K.Hill feasibility study, which is expected later this year, we are working on a further revision to the PEA. This updated version contains a modified, simpler processing strategy to produce HPMSM, rather than HPEMM as per the current PEA. The updated strategy is an end-market driven decision, which we believe...